|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.84 CNY | +0.32% |
|
-4.75% | -10.10% |
| 04-24 | Dashenlin Pharma's Q1 Profit Rises 11% | MT |
| 04-24 | Dashenlin Pharma's 2025 Profit Jumps 35%, Revenue Rises 4% | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 24.49 | +55.08% | 8 | ||||||
| 62.03 | +97.18% | 16 | ||||||
| 5.061 | +67.25% | 17 | ||||||
| 2,979 | +25.83% | 10 | ||||||
| 33.72 | +64.54% | 12 | ||||||
| 350.38 | +46.84% | 8 | ||||||
| 125.87 | +32.78% | 9 | ||||||
| - | - | 1,415 | +201.06% | 1 | ||||
| 43.17 | +6.56% | 6 | ||||||
| 35.78 | +9.24% | 8 | ||||||
| 74.28 | +51.59% | 9 | ||||||
| 1,168.71 | +37.19% | 7 | ||||||
| 60.52 | +37.56% | 8 | ||||||
| 14.86 | +34.5% | 5 | ||||||
| - | 90 | +15.9% | 2 | |||||
| - | 5,350 | +60.18% | 2 | |||||
| 8.417 | +114.71% | 6 | ||||||
| Average | 696.55 | +56.35% | 8 | ||||||
| Weighted average by Cap. | 533.7 | +66.09% | 11 |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition